Prevencio
Dr. William (Bill) LaFramboise is a Prevencio co-founder who has an active and diverse research program spanning numerous departments and institutions at the Allegheny Health Network. Currently, he is Chief Genomics Technology Officer, Allegheny Health Network, and Allegheny Cancer Institute. One of Dr. LaFramboise's research interests is the study of clinically important cardiac proteins.
Previously, Dr. LaFramboise was the Director of the Clinical Sequencing Facility/Cancer Biomarkers Facility at the University of Pittsburgh Medical Center (UPMC). Dr. LaFramboise also collaborated with the UPMC Department of Cardiology.
Dr. LaFramboise has held positions including Associate Professor and Director of the Applied Molecular Research Microarray Facility, Department of Cardiothoracic Surgery, at the Allegheny General Hospital in Pittsburgh, PA; Director of Laboratory Development & Operations at TissueInformatics, Inc., in Pittsburgh; and Director of Cellular & Molecular Mycology Laboratory in the Department of Pediatrics at Drexel University Medical School.
This person is not in any offices
Prevencio
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.